US Patent 10538572 T cell immunotherapy specific for WT-1
Patent 10538572 was granted and assigned to Fred Hutchinson Cancer Research Center on January, 2020 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 11 Dec, 2023
Golden AI
Edits made to:
Article (+243 characters)
Article
Patent abstract
The present disclosure provides high affinity and enhanced affinity T cell receptors specific for human Wilms tumor protein 1 (WT-1) epitopes for use in treating diseases or disorders, such as cancer cells that overexpress WT-1.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Hieu Nguyen0
Philip D. Greenberg0
Thomas M. Schmitt0
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
105385720
Date of Patent
January 21, 2020
0Patent Application Number
148137820
Date Filed
July 30, 2015
0Patent Primary Examiner
Edits on 1 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10538572 T cell immunotherapy specific for WT-1
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10538572
Date of patent
January 21, 2020
Patent application number
14813782
Date Filed
July 30, 2015
Patent primary examiner
Find more entities like US Patent 10538572 T cell immunotherapy specific for WT-1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.